The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial

References

• Butt JH, Franzmann U, Kruuse C. Endothelial function in migraine with aura–a systematic review. Headache. 2015;55(1):35–54. doi: 10.1111/head.12494
   PubMed Web of Science ®Google Scholar
• Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4
   PubMed Web of Science ®Google Scholar
• Stuart S, Griffiths LR. A possible role for mitochondrial dysfunction in migraine. Mol Genet Genomics. 2012;287(11-12):837–44. doi: 10.1007/s00438-012-0723-7
   PubMed Web of Science ®Google Scholar
• Silberstein S, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337–45. doi: 10.1212/WNL.0b013e3182535d20
   PubMed Web of Science ®Google Scholar
• Daniel O, Mauskop A. Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol. 2016;18(4):14–21. doi: 10.1007/s11940-016-0398-1
   PubMed Web of Science ®Google Scholar
• Rajapakse T, Pringsheim T. Nutraceuticals in migraine: a summary of existing guidelines for use. Headache. 2016;56(4):808–16. doi: 10.1111/head.12789
   PubMed Web of Science ®Google Scholar
• Sandor P, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–5. doi: 10.1212/01.WNL.0000151975.03598.ED
   PubMed Web of Science ®Google Scholar
• Rozen T, Oshinsky M, Gebeline C, Bradley K, Young W, Shechter A, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22(2):137–41. doi: 10.1046/j.1468-2982.2002.00335.x
   PubMed Web of Science ®Google Scholar
• Condo M, Posar A, Arbizzani A, Parmeggiani A. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain. 2009;10(5):361–5. doi: 10.1007/s10194-009-0142-2
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V, Wessely P, Meyer C, Isler H, Evers S, Grotemeyer K, et al. Magnesium in the prophylaxis of migraine-a double-blind, placebo-controlled study. Cephalalgia. 1996;16(6):436–40. doi: 10.1046/j.1468-2982.1996.1606436.x
   PubMed Web of Science ®Google Scholar
• Lopresti AL, Hood SD, Drummond PD. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. J Psychopharmacol. 2012;26(12):1512–24. doi: 10.1177/0269881112458732
   PubMed Web of Science ®Google Scholar
• Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, et al. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem. 2010;21(12):1153–61. doi: 10.1016/j.jnutbio.2009.09.012
   PubMed Web of Science ®Google Scholar
• Sohilait MR, Pranowo HD, Haryadi W. Molecular docking analysis of curcumin analogues with COX-2. Bioinformation. 2017;13(11):356–9. doi: 10.6026/97320630013356
   PubMed Web of Science ®Google Scholar
• Raghu G, Karunanithi A, Kannan I, Preetha LK. Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. Natl J Physiol Pharm Pharmacol. 2018;8(2):244–50.
   Google Scholar
• Ng QX, Koh SSH, Chan HW, Ho CYX. Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc. 2017;18(6):503–8. doi: 10.1016/j.jamda.2016.12.071
   PubMed Web of Science ®Google Scholar
• Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q(1)(0) supplementation on heart failure: a meta-analysis. Am J Clin Nutr. 2013;97(2):268–75. doi: 10.3945/ajcn.112.040741
   PubMed Web of Science ®Google Scholar
• Al Gadban MM, Smith KJ, Soodavar F, Piansay C, Chassereau C, Twal WO, et al. Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress. PLoS One. 2010;5(9):1–10. doi: 10.1371/journal.pone.0012534
   Web of Science ®Google Scholar
• Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40(5):445–53. doi: 10.1080/10715760600617843
   PubMed Web of Science ®Google Scholar
• Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Neurosci. 2019:1–8. DOI:10.1080/1028415X.2019.1572940 [Epub ahead of print] doi: 10.1080/1028415X.2019.1627770
   Google Scholar
• Mehrpooya M, Yasrebifar F, Haghighi M, Mohammadi Y, Jahangard L. Evaluating the effect of coenzyme Q10 augmentation on treatment of bipolar depression: a double-blind controlled clinical trial. J Clin Psychopharmacol. 2018;38(5):460–6. doi: 10.1097/JCP.0000000000000938
   PubMed Web of Science ®Google Scholar
• Sanoobar M, Dehghan P, Khalili M, Azimi A. Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci. 2016;19(3):138–43. doi: 10.1179/1476830515Y.0000000002
   PubMed Web of Science ®Google Scholar
• Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: effects on clinical features and inflammatory markers. Nutr Neurosci. 2018:1–9. DOI:10.1080/1028415X.2017.1421039 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Hershey AD, Powers SW, Vockell ALB, LeCates SL, Ellinor PL, Segers A, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47(1):73–80. doi: 10.1111/j.1526-4610.2007.00652.x
   PubMed Web of Science ®Google Scholar
• Shoeibi A, Olfati N, Sabi MS, Salehi M, Mali S, Oryani MA. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta Neurol Belg. 2017;117(1):103–9. doi: 10.1007/s13760-016-0697-z
   PubMed Web of Science ®Google Scholar
• Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011;31(8):897–905. doi: 10.1177/0333102411406755
   PubMed Web of Science ®Google Scholar
• Valverde Y, Benson B, Gupta M, Gupta K. Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice. Haematologica. 2016;101(2):e44–7. doi: 10.3324/haematol.2015.137489
   PubMed Web of Science ®Google Scholar
• International Headache Society. International Classification of Headache Disorders (ICHD-3). 2018. Available from: https://www.ichd-3.org/.
   Google Scholar
• Rahimi HR, Jaafari MR, Mohammadpour AH, Abnous K, Ghayour Mobarhan M, Ramezanzadeh E, et al. Curcumin: reintroduced therapeutic agent from traditional medicine for alcoholic liver disease. Asia Pac J Med Toxicol. 2015;4(1):25–30.
   Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218. doi: 10.1208/s12248-012-9432-8
   PubMed Web of Science ®Google Scholar
• Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum (Minneap Minn). 2012;18(4):796–806.
   PubMedGoogle Scholar
• Committee IR. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. 2005. Available from: http://www ipaq ki se/scoring pdf.
   Google Scholar
• Blau JN, Thavapalan M. Preventing migraine: a study of precipitating factors. Headache. 1988;28(7):481–3. doi: 10.1111/j.1526-4610.1988.hed2807481.x
   PubMed Web of Science ®Google Scholar
• Kim SY, Park SP. The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study. J Headache Pain. 2014;15(1):68–75. doi: 10.1186/1129-2377-15-68
   PubMed Web of Science ®Google Scholar
• Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, et al. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache. 2012;52(1):3–17. doi: 10.1111/j.1526-4610.2011.02046.x
   PubMed Web of Science ®Google Scholar
• Peng KP, Wang SJ. Migraine diagnosis: screening items, instruments, and scales. Acta Anaesthesiol Taiwan. 2012;50(2):69–73. doi: 10.1016/j.aat.2012.05.002
   PubMedGoogle Scholar
• Raggi A, Giovannetti AM, Schiavolin S, Leonardi M, Bussone G, Grazzi L, et al. Validating the Migraine-Specific Quality of Life Questionnaire v2. 1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse. Qual Life Res. 2014;23(4):1273–7. doi: 10.1007/s11136-013-0556-9
   PubMed Web of Science ®Google Scholar
• Caproni S, Bianchi E, Cupini LM, Corbelli I, Beghi E, Calabresi P, et al. Migraine-specific quality of life questionnaire and relapse of medication overuse headache. BMC Neurol. 2015;15:85–9. doi: 10.1186/s12883-015-0339-8
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20–8. doi: 10.1212/WNL.56.suppl_1.S20
   PubMed Web of Science ®Google Scholar
• Zandifar A, Asgari F, Haghdoost F, Masjedi SS, Manouchehri N, Banihashemi M, et al. Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients. Biomed Res Int. 2014;978064:1–7.
   Google Scholar
• Shin HE, Park JW, Kim YI, Lee KS. Headache Impact Test-6 (HIT-6) scores for migraine patients: their relation to disability as measured from a headache diary. J Clin Neurol. 2008;4(4):158–63. doi: 10.3988/jcn.2008.4.4.158
   PubMed Web of Science ®Google Scholar
• Zandifar A, Masjedi SS, Haghdoost F, Asgari F, Manouchehri N, Banihashemi M, et al. The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines. Sci World J. 2013;950245:1–6.
   Google Scholar
• Zandifar A, Banihashemi M, Haghdoost F, Masjedi SS, Manouchehri N, Asgari F, et al. Reliability and validity of the Persian HIT-6 questionnaire in migraine and tension-type headache. Pain Pract. 2014;14(7):625–31. doi: 10.1111/papr.12120
   PubMed Web of Science ®Google Scholar
• Abdolahi M, Sarraf P, Javanbakht MH, Honarvar NM, Hatami M, Soveyd N, et al. A novel combination of omega-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine: a randomized clinical trial study. CNS Neurol Disord Drug Targets. 2018;17(6):430–8. doi: 10.2174/1871527317666180625101643
   PubMed Web of Science ®Google Scholar
• Hoppe U, Bergemann J, Diembeck W, Ennen J, Gohla S, Harris I, et al. Coenzyme Q_ {10}, a cutaneous antioxidant and energizer. Biofactors. 1999;9(2-4):371–8. doi: 10.1002/biof.5520090238
   PubMed Web of Science ®Google Scholar
• Tapia E, Soto V, Ortiz-Vega KM, Zarco-Marquez G, Molina-Jijon E, Cristobal-Garcia M, et al. Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid Med Cell Longev. 2012;269039:1–14. doi: 10.1155/2012/269039
   Web of Science ®Google Scholar
• Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 1993;43(6 Suppl 3):S16–20.
   PubMed Web of Science ®Google Scholar
• Tietjen GE, Khubchandani J. Vascular biomarkers in migraine. Cephalalgia. 2015;35(2):95–117. doi: 10.1177/0333102414544976
   PubMed Web of Science ®Google Scholar
• Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006;171(1):184–8. doi: 10.1016/j.jneuroim.2005.10.005
   PubMed Web of Science ®Google Scholar
• Edvinsson L. The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache. 2017;57:47–55. doi: 10.1111/head.13081
   PubMed Web of Science ®Google Scholar
• Jacob A, Wu R, Zhou M, Wang P. Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation. PPAR Res. 2007;89369:1–5. doi: 10.1155/2007/89369
   Web of Science ®Google Scholar
• Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Khodadadi B, Jazayeri S, et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci. 2015;18(4):169–76. doi: 10.1179/1476830513Y.0000000106
   PubMed Web of Science ®Google Scholar
• Lee B-J, Tseng Y-F, Yen C-H, Lin P-T. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013;12(1):142–50. doi: 10.1186/1475-2891-12-142
   PubMed Web of Science ®Google Scholar
• Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, et al. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull. 2011;34(5):660–5. doi: 10.1248/bpb.34.660
   PubMed Web of Science ®Google Scholar